Blood clues during radiation may reveal breast cancer recurrence risk
NCT ID NCT06418126
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study looks at whether certain proteins in the blood, called cytokines, can help predict if triple-negative breast cancer will come back early after radiation. About 15 women who have already had chemotherapy and surgery will give blood samples during their radiation treatment. The goal is to find a way to tell which patients are at higher risk of recurrence, so doctors can adjust their care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut de cancérologie Strasbourg europe
Strasbourg, 67033, France
Conditions
Explore the condition pages connected to this study.